Goto

Collaborating Authors

Long-distance robot-assisted heart surgery and beyond

Robohub

In 2018, five patients at the Apex Heart Institute in Ahmedabad, India, received treatment for coronary artery disease (CAD) the same way 3 million others do each year: a small balloon was inserted into an artery in the heart and inflated, making way for the placement of a stent to keep the vital pathway open. The procedure, known as percutaneous coronary intervention (PCI), is the standard treatment for atherosclerosis, a common CAD marked by the buildup of plaque inside the arteries and a subsequent restriction of blood flow. Like many patients before them, their operation was assisted by a robot--the CorPath GRX robotic platform from Corindus, A Siemens Healthineers Company. Yet unlike anyone else before them, these five patients were part of an amazing first: their principal physician was not in the room with them during the procedure. In fact, he was 20 miles away, guiding the robot--performing the operation to perfection--from a remote workstation.


First long-distance heart surgery performed via robot ZDNet

#artificialintelligence

A doctor in India has performed a series of five percutaneous coronary intervention (PCI) procedures on patients who were 20 miles away from him. The feat was pulled off using a precision vascular robot developed by Corindus. The results of the surgeries, which were successful, have just been published in EClinicalMedicine, a spin-off of medical journal The Lancet. The feat is an example of telemedicine, an emerging field that leverages advances in networking, robotics, mixed reality, and communications technologies to beam in medical experts to remote locations for everything from consultations to surgical procedures. Telemedicine, which could decentralize healthcare by distributing doctors into local communities virtually, could ease shortages of nurses and doctors and potentially cut healthcare costs.


First long-distance heart surgery performed via robot ZDNet

#artificialintelligence

A doctor in India has performed a series of five percutaneous coronary intervention (PCI) procedures on patients who were 20 miles away from him. The feat was pulled off using a precision vascular robot developed by Corindus. The results of the surgeries, which were successful, have just been published in EClinicalMedicine, a spin-off of medical journal The Lancet. The feat is an example of telemedicine, an emerging field that leverages advances in networking, robotics, mixed reality, and communications technologies to beam in medical experts to remote locations for everything from consultations to surgical procedures. Telemedicine, which could decentralize healthcare by distributing doctors into local communities virtually, could ease shortages of nurses and doctors and potentially cut healthcare costs.


Robot used in landmark brain surgery ZDNet

#artificialintelligence

Robots are used in a variety of surgical procedures these days, but the brain has largely been a no-go zone for robot assistants in the OR. With the successful completion of an in-human robotic-assisted neurovascular intervention this month, that's set to change. The surgery was led by Dr. Vitor Mendes Pereira, a neurosurgeon and neuroradiologist at the Toronto Western Hospital and Krembil Brain Institute in Canada. Dr. Pereira's team utilized a vascular robotic device developed by Corindus. "The field of neurovascular intervention is changing rapidly, but there remains a significant need to expand access to care and reduce treatment times," said Mark Toland, CEO of Corindus.


Siemens Healthineers completes Corindus acquisition

#artificialintelligence

Siemens Healthineers AG completed the acquisition of 100 percent of Corindus Vascular Robotics, Inc. effective October 29, 2019. Prior to the closing of the acquisition, Corindus held a shareholders' meeting on October 25, 2019, at which 87.5 percent of their stockholders approved the acquisition. The relevant governmental authorities previously granted the approvals required to complete the acquisition. "With the completion of the acquisition, we are opening up a new field for our Advanced Therapies business, tapping into adjacent growth markets with great potential for the future. We are taking an important step forward in the upgrading phase of our 2025 strategy," said Bernd Montag, CEO of Siemens Healthineers AG.